| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 6e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0004 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |